Gufic Biosciences surges on receiving two Patent Certificates from Intellectual Property India

30 Nov 2017 Evaluate

Gufic Biosciences is currently trading at Rs. 97.40, up by 1.90 points or 1.99% from its previous closing of Rs. 95.50 on the BSE.

The scrip opened at Rs. 94.90 and has touched a high and low of Rs. 103.00 and Rs. 92.85 respectively. So far 299877 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 103.00 on 30-Nov-2017 and a 52 week low of Rs. 45.00 on 02-Dec-2016.

Last one week high and low of the scrip stood at Rs. 103.00 and Rs. 90.10 respectively. The current market cap of the company is Rs. 743.72 crore.

The promoters holding in the company stood at 69.98%, while Institutions and Non-Institutions held 8.88% and 21.14% respectively.

Gufic Biosciences has received two Patent Certificates from the Intellectual Property India, The Patent Office. The Government of India has granted patents to the company for the following formulations—a freeze dried pharmaceutical formulation of rifabutin and process for preparation thereof and process for preparation of parental formulation of Micafungin Sodium.

Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.

Gufic Biosciences Share Price

355.20 -2.65 (-0.74%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×